nodes	percent_of_prediction	percent_of_DWPC	metapath
Fondaparinux sodium—Creatinine increased—Doxorubicin—muscle cancer	0.00337	0.00337	CcSEcCtD
Fondaparinux sodium—Hepatobiliary disease—Etoposide—muscle cancer	0.00327	0.00327	CcSEcCtD
Fondaparinux sodium—Back pain—Vincristine—muscle cancer	0.00322	0.00322	CcSEcCtD
Fondaparinux sodium—Sepsis—Methotrexate—muscle cancer	0.00321	0.00321	CcSEcCtD
Fondaparinux sodium—Hepatocellular injury—Doxorubicin—muscle cancer	0.0032	0.0032	CcSEcCtD
Fondaparinux sodium—Ventricular tachycardia—Doxorubicin—muscle cancer	0.0032	0.0032	CcSEcCtD
Fondaparinux sodium—Hypoaesthesia—Etoposide—muscle cancer	0.00309	0.00309	CcSEcCtD
Fondaparinux sodium—Anaemia—Vincristine—muscle cancer	0.00308	0.00308	CcSEcCtD
Fondaparinux sodium—Oedema—Dactinomycin—muscle cancer	0.00305	0.00305	CcSEcCtD
Fondaparinux sodium—Fluid retention—Doxorubicin—muscle cancer	0.00304	0.00304	CcSEcCtD
Fondaparinux sodium—Infection—Dactinomycin—muscle cancer	0.00303	0.00303	CcSEcCtD
Fondaparinux sodium—Blood urea increased—Doxorubicin—muscle cancer	0.00303	0.00303	CcSEcCtD
Fondaparinux sodium—Vertigo—Vincristine—muscle cancer	0.003	0.003	CcSEcCtD
Fondaparinux sodium—Thrombocytopenia—Dactinomycin—muscle cancer	0.00298	0.00298	CcSEcCtD
Fondaparinux sodium—Renal failure acute—Methotrexate—muscle cancer	0.00291	0.00291	CcSEcCtD
Fondaparinux sodium—Anorexia—Dactinomycin—muscle cancer	0.0029	0.0029	CcSEcCtD
Fondaparinux sodium—Convulsion—Vincristine—muscle cancer	0.00289	0.00289	CcSEcCtD
Fondaparinux sodium—Flushing—Etoposide—muscle cancer	0.00288	0.00288	CcSEcCtD
Fondaparinux sodium—Angiopathy—Etoposide—muscle cancer	0.00281	0.00281	CcSEcCtD
Fondaparinux sodium—Immune system disorder—Etoposide—muscle cancer	0.0028	0.0028	CcSEcCtD
Fondaparinux sodium—Mediastinal disorder—Etoposide—muscle cancer	0.0028	0.0028	CcSEcCtD
Fondaparinux sodium—Sepsis—Doxorubicin—muscle cancer	0.00278	0.00278	CcSEcCtD
Fondaparinux sodium—Cerebrovascular accident—Methotrexate—muscle cancer	0.00274	0.00274	CcSEcCtD
Fondaparinux sodium—Oedema—Vincristine—muscle cancer	0.00272	0.00272	CcSEcCtD
Fondaparinux sodium—Anaphylactic shock—Vincristine—muscle cancer	0.00272	0.00272	CcSEcCtD
Fondaparinux sodium—Infection—Vincristine—muscle cancer	0.0027	0.0027	CcSEcCtD
Fondaparinux sodium—Phlebitis—Doxorubicin—muscle cancer	0.0027	0.0027	CcSEcCtD
Fondaparinux sodium—Nervous system disorder—Vincristine—muscle cancer	0.00267	0.00267	CcSEcCtD
Fondaparinux sodium—Thrombocytopenia—Vincristine—muscle cancer	0.00266	0.00266	CcSEcCtD
Fondaparinux sodium—Hepatic function abnormal—Doxorubicin—muscle cancer	0.00266	0.00266	CcSEcCtD
Fondaparinux sodium—Decreased appetite—Dactinomycin—muscle cancer	0.00265	0.00265	CcSEcCtD
Fondaparinux sodium—Dysgeusia—Etoposide—muscle cancer	0.00264	0.00264	CcSEcCtD
Fondaparinux sodium—Hyperhidrosis—Vincristine—muscle cancer	0.00263	0.00263	CcSEcCtD
Fondaparinux sodium—Fatigue—Dactinomycin—muscle cancer	0.00263	0.00263	CcSEcCtD
Fondaparinux sodium—Back pain—Etoposide—muscle cancer	0.00261	0.00261	CcSEcCtD
Fondaparinux sodium—Pain—Dactinomycin—muscle cancer	0.0026	0.0026	CcSEcCtD
Fondaparinux sodium—Vascular purpura—Doxorubicin—muscle cancer	0.0026	0.0026	CcSEcCtD
Fondaparinux sodium—Anorexia—Vincristine—muscle cancer	0.00259	0.00259	CcSEcCtD
Fondaparinux sodium—Cardiac failure congestive—Doxorubicin—muscle cancer	0.00256	0.00256	CcSEcCtD
Fondaparinux sodium—Irritability—Methotrexate—muscle cancer	0.00256	0.00256	CcSEcCtD
Fondaparinux sodium—Hypotension—Vincristine—muscle cancer	0.00254	0.00254	CcSEcCtD
Fondaparinux sodium—Renal failure acute—Doxorubicin—muscle cancer	0.00252	0.00252	CcSEcCtD
Fondaparinux sodium—Feeling abnormal—Dactinomycin—muscle cancer	0.00251	0.00251	CcSEcCtD
Fondaparinux sodium—Anaemia—Etoposide—muscle cancer	0.0025	0.0025	CcSEcCtD
Fondaparinux sodium—Gastrointestinal pain—Dactinomycin—muscle cancer	0.00249	0.00249	CcSEcCtD
Fondaparinux sodium—Hot flush—Doxorubicin—muscle cancer	0.00249	0.00249	CcSEcCtD
Fondaparinux sodium—Menopausal symptoms—Doxorubicin—muscle cancer	0.00247	0.00247	CcSEcCtD
Fondaparinux sodium—Insomnia—Vincristine—muscle cancer	0.00246	0.00246	CcSEcCtD
Fondaparinux sodium—Renal impairment—Doxorubicin—muscle cancer	0.00244	0.00244	CcSEcCtD
Fondaparinux sodium—Paraesthesia—Vincristine—muscle cancer	0.00244	0.00244	CcSEcCtD
Fondaparinux sodium—Dermatitis bullous—Doxorubicin—muscle cancer	0.00243	0.00243	CcSEcCtD
Fondaparinux sodium—Vertigo—Etoposide—muscle cancer	0.00243	0.00243	CcSEcCtD
Fondaparinux sodium—Purpura—Doxorubicin—muscle cancer	0.00241	0.00241	CcSEcCtD
Fondaparinux sodium—Abdominal pain—Dactinomycin—muscle cancer	0.00241	0.00241	CcSEcCtD
Fondaparinux sodium—Body temperature increased—Dactinomycin—muscle cancer	0.00241	0.00241	CcSEcCtD
Fondaparinux sodium—Cardiac failure—Doxorubicin—muscle cancer	0.00238	0.00238	CcSEcCtD
Fondaparinux sodium—Loss of consciousness—Etoposide—muscle cancer	0.00237	0.00237	CcSEcCtD
Fondaparinux sodium—Cerebrovascular accident—Doxorubicin—muscle cancer	0.00237	0.00237	CcSEcCtD
Fondaparinux sodium—Decreased appetite—Vincristine—muscle cancer	0.00237	0.00237	CcSEcCtD
Fondaparinux sodium—Cough—Etoposide—muscle cancer	0.00236	0.00236	CcSEcCtD
Fondaparinux sodium—Gastrointestinal disorder—Vincristine—muscle cancer	0.00235	0.00235	CcSEcCtD
Fondaparinux sodium—Fatigue—Vincristine—muscle cancer	0.00235	0.00235	CcSEcCtD
Fondaparinux sodium—Convulsion—Etoposide—muscle cancer	0.00234	0.00234	CcSEcCtD
Fondaparinux sodium—Pain—Vincristine—muscle cancer	0.00233	0.00233	CcSEcCtD
Fondaparinux sodium—Constipation—Vincristine—muscle cancer	0.00233	0.00233	CcSEcCtD
Fondaparinux sodium—Pain in extremity—Doxorubicin—muscle cancer	0.00233	0.00233	CcSEcCtD
Fondaparinux sodium—Chest pain—Etoposide—muscle cancer	0.0023	0.0023	CcSEcCtD
Fondaparinux sodium—Unspecified disorder of skin and subcutaneous tissue—Etoposide—muscle cancer	0.00228	0.00228	CcSEcCtD
Fondaparinux sodium—Hypersensitivity—Dactinomycin—muscle cancer	0.00224	0.00224	CcSEcCtD
Fondaparinux sodium—Gastrointestinal pain—Vincristine—muscle cancer	0.00222	0.00222	CcSEcCtD
Fondaparinux sodium—Confusional state—Etoposide—muscle cancer	0.00222	0.00222	CcSEcCtD
Fondaparinux sodium—Cardiac arrest—Doxorubicin—muscle cancer	0.00221	0.00221	CcSEcCtD
Fondaparinux sodium—Anaphylactic shock—Etoposide—muscle cancer	0.0022	0.0022	CcSEcCtD
Fondaparinux sodium—Infection—Etoposide—muscle cancer	0.00219	0.00219	CcSEcCtD
Fondaparinux sodium—Asthenia—Dactinomycin—muscle cancer	0.00219	0.00219	CcSEcCtD
Fondaparinux sodium—Blood creatinine increased—Doxorubicin—muscle cancer	0.00218	0.00218	CcSEcCtD
Fondaparinux sodium—Dehydration—Doxorubicin—muscle cancer	0.00216	0.00216	CcSEcCtD
Fondaparinux sodium—Thrombocytopenia—Etoposide—muscle cancer	0.00216	0.00216	CcSEcCtD
Fondaparinux sodium—Tachycardia—Etoposide—muscle cancer	0.00215	0.00215	CcSEcCtD
Fondaparinux sodium—Abdominal pain—Vincristine—muscle cancer	0.00215	0.00215	CcSEcCtD
Fondaparinux sodium—Body temperature increased—Vincristine—muscle cancer	0.00215	0.00215	CcSEcCtD
Fondaparinux sodium—Skin disorder—Etoposide—muscle cancer	0.00214	0.00214	CcSEcCtD
Fondaparinux sodium—Hyperhidrosis—Etoposide—muscle cancer	0.00213	0.00213	CcSEcCtD
Fondaparinux sodium—Hypokalaemia—Doxorubicin—muscle cancer	0.00212	0.00212	CcSEcCtD
Fondaparinux sodium—Anorexia—Etoposide—muscle cancer	0.0021	0.0021	CcSEcCtD
Fondaparinux sodium—Aspartate aminotransferase increased—Doxorubicin—muscle cancer	0.00209	0.00209	CcSEcCtD
Fondaparinux sodium—Diarrhoea—Dactinomycin—muscle cancer	0.00208	0.00208	CcSEcCtD
Fondaparinux sodium—Infestation NOS—Methotrexate—muscle cancer	0.00207	0.00207	CcSEcCtD
Fondaparinux sodium—Infestation—Methotrexate—muscle cancer	0.00207	0.00207	CcSEcCtD
Fondaparinux sodium—Hypotension—Etoposide—muscle cancer	0.00206	0.00206	CcSEcCtD
Fondaparinux sodium—Gastritis—Doxorubicin—muscle cancer	0.00206	0.00206	CcSEcCtD
Fondaparinux sodium—Alanine aminotransferase increased—Doxorubicin—muscle cancer	0.00205	0.00205	CcSEcCtD
Fondaparinux sodium—Renal failure—Methotrexate—muscle cancer	0.00203	0.00203	CcSEcCtD
Fondaparinux sodium—Abdominal distension—Doxorubicin—muscle cancer	0.00202	0.00202	CcSEcCtD
Fondaparinux sodium—Dysphagia—Doxorubicin—muscle cancer	0.00201	0.00201	CcSEcCtD
Fondaparinux sodium—Hypersensitivity—Vincristine—muscle cancer	0.002	0.002	CcSEcCtD
Fondaparinux sodium—Paraesthesia—Etoposide—muscle cancer	0.00198	0.00198	CcSEcCtD
Fondaparinux sodium—Haematuria—Methotrexate—muscle cancer	0.00197	0.00197	CcSEcCtD
Fondaparinux sodium—Dyspnoea—Etoposide—muscle cancer	0.00197	0.00197	CcSEcCtD
Fondaparinux sodium—Somnolence—Etoposide—muscle cancer	0.00196	0.00196	CcSEcCtD
Fondaparinux sodium—Hepatobiliary disease—Methotrexate—muscle cancer	0.00196	0.00196	CcSEcCtD
Fondaparinux sodium—Epistaxis—Methotrexate—muscle cancer	0.00195	0.00195	CcSEcCtD
Fondaparinux sodium—Asthenia—Vincristine—muscle cancer	0.00195	0.00195	CcSEcCtD
Fondaparinux sodium—Vomiting—Dactinomycin—muscle cancer	0.00194	0.00194	CcSEcCtD
Fondaparinux sodium—Bronchitis—Doxorubicin—muscle cancer	0.00193	0.00193	CcSEcCtD
Fondaparinux sodium—Rash—Dactinomycin—muscle cancer	0.00192	0.00192	CcSEcCtD
Fondaparinux sodium—Decreased appetite—Etoposide—muscle cancer	0.00192	0.00192	CcSEcCtD
Fondaparinux sodium—Gastrointestinal disorder—Etoposide—muscle cancer	0.0019	0.0019	CcSEcCtD
Fondaparinux sodium—Fatigue—Etoposide—muscle cancer	0.0019	0.0019	CcSEcCtD
Fondaparinux sodium—Pain—Etoposide—muscle cancer	0.00188	0.00188	CcSEcCtD
Fondaparinux sodium—Constipation—Etoposide—muscle cancer	0.00188	0.00188	CcSEcCtD
Fondaparinux sodium—Haemoglobin—Methotrexate—muscle cancer	0.00187	0.00187	CcSEcCtD
Fondaparinux sodium—Diarrhoea—Vincristine—muscle cancer	0.00186	0.00186	CcSEcCtD
Fondaparinux sodium—Haemorrhage—Methotrexate—muscle cancer	0.00186	0.00186	CcSEcCtD
Fondaparinux sodium—Feeling abnormal—Etoposide—muscle cancer	0.00182	0.00182	CcSEcCtD
Fondaparinux sodium—Nausea—Dactinomycin—muscle cancer	0.00181	0.00181	CcSEcCtD
Fondaparinux sodium—Gastrointestinal pain—Etoposide—muscle cancer	0.0018	0.0018	CcSEcCtD
Fondaparinux sodium—Dizziness—Vincristine—muscle cancer	0.0018	0.0018	CcSEcCtD
Fondaparinux sodium—Infestation—Doxorubicin—muscle cancer	0.00179	0.00179	CcSEcCtD
Fondaparinux sodium—Infestation NOS—Doxorubicin—muscle cancer	0.00179	0.00179	CcSEcCtD
Fondaparinux sodium—Renal failure—Doxorubicin—muscle cancer	0.00176	0.00176	CcSEcCtD
Fondaparinux sodium—Urticaria—Etoposide—muscle cancer	0.00175	0.00175	CcSEcCtD
Fondaparinux sodium—Body temperature increased—Etoposide—muscle cancer	0.00174	0.00174	CcSEcCtD
Fondaparinux sodium—Abdominal pain—Etoposide—muscle cancer	0.00174	0.00174	CcSEcCtD
Fondaparinux sodium—Urinary tract infection—Doxorubicin—muscle cancer	0.00174	0.00174	CcSEcCtD
Fondaparinux sodium—Vomiting—Vincristine—muscle cancer	0.00173	0.00173	CcSEcCtD
Fondaparinux sodium—Rash—Vincristine—muscle cancer	0.00172	0.00172	CcSEcCtD
Fondaparinux sodium—Dermatitis—Vincristine—muscle cancer	0.00171	0.00171	CcSEcCtD
Fondaparinux sodium—Haematuria—Doxorubicin—muscle cancer	0.00171	0.00171	CcSEcCtD
Fondaparinux sodium—Headache—Vincristine—muscle cancer	0.0017	0.0017	CcSEcCtD
Fondaparinux sodium—Hepatobiliary disease—Doxorubicin—muscle cancer	0.0017	0.0017	CcSEcCtD
Fondaparinux sodium—Epistaxis—Doxorubicin—muscle cancer	0.00169	0.00169	CcSEcCtD
Fondaparinux sodium—Angiopathy—Methotrexate—muscle cancer	0.00169	0.00169	CcSEcCtD
Fondaparinux sodium—Immune system disorder—Methotrexate—muscle cancer	0.00168	0.00168	CcSEcCtD
Fondaparinux sodium—Mediastinal disorder—Methotrexate—muscle cancer	0.00167	0.00167	CcSEcCtD
Fondaparinux sodium—Hypersensitivity—Etoposide—muscle cancer	0.00162	0.00162	CcSEcCtD
Fondaparinux sodium—Malnutrition—Methotrexate—muscle cancer	0.00162	0.00162	CcSEcCtD
Fondaparinux sodium—Haemoglobin—Doxorubicin—muscle cancer	0.00162	0.00162	CcSEcCtD
Fondaparinux sodium—Nausea—Vincristine—muscle cancer	0.00162	0.00162	CcSEcCtD
Fondaparinux sodium—Haemorrhage—Doxorubicin—muscle cancer	0.00161	0.00161	CcSEcCtD
Fondaparinux sodium—Hypoaesthesia—Doxorubicin—muscle cancer	0.0016	0.0016	CcSEcCtD
Fondaparinux sodium—Oedema peripheral—Doxorubicin—muscle cancer	0.00159	0.00159	CcSEcCtD
Fondaparinux sodium—Dysgeusia—Methotrexate—muscle cancer	0.00158	0.00158	CcSEcCtD
Fondaparinux sodium—Asthenia—Etoposide—muscle cancer	0.00158	0.00158	CcSEcCtD
Fondaparinux sodium—Back pain—Methotrexate—muscle cancer	0.00156	0.00156	CcSEcCtD
Fondaparinux sodium—Pruritus—Etoposide—muscle cancer	0.00156	0.00156	CcSEcCtD
Fondaparinux sodium—Vision blurred—Methotrexate—muscle cancer	0.00152	0.00152	CcSEcCtD
Fondaparinux sodium—Diarrhoea—Etoposide—muscle cancer	0.00151	0.00151	CcSEcCtD
Fondaparinux sodium—Anaemia—Methotrexate—muscle cancer	0.0015	0.0015	CcSEcCtD
Fondaparinux sodium—Flushing—Doxorubicin—muscle cancer	0.00149	0.00149	CcSEcCtD
Fondaparinux sodium—Angiopathy—Doxorubicin—muscle cancer	0.00146	0.00146	CcSEcCtD
Fondaparinux sodium—Dizziness—Etoposide—muscle cancer	0.00146	0.00146	CcSEcCtD
Fondaparinux sodium—Immune system disorder—Doxorubicin—muscle cancer	0.00145	0.00145	CcSEcCtD
Fondaparinux sodium—Vertigo—Methotrexate—muscle cancer	0.00145	0.00145	CcSEcCtD
Fondaparinux sodium—Mediastinal disorder—Doxorubicin—muscle cancer	0.00145	0.00145	CcSEcCtD
Fondaparinux sodium—Arrhythmia—Doxorubicin—muscle cancer	0.00144	0.00144	CcSEcCtD
Fondaparinux sodium—Cough—Methotrexate—muscle cancer	0.00141	0.00141	CcSEcCtD
Fondaparinux sodium—Convulsion—Methotrexate—muscle cancer	0.0014	0.0014	CcSEcCtD
Fondaparinux sodium—Vomiting—Etoposide—muscle cancer	0.0014	0.0014	CcSEcCtD
Fondaparinux sodium—Malnutrition—Doxorubicin—muscle cancer	0.0014	0.0014	CcSEcCtD
Fondaparinux sodium—Rash—Etoposide—muscle cancer	0.00139	0.00139	CcSEcCtD
Fondaparinux sodium—Dermatitis—Etoposide—muscle cancer	0.00139	0.00139	CcSEcCtD
Fondaparinux sodium—Headache—Etoposide—muscle cancer	0.00138	0.00138	CcSEcCtD
Fondaparinux sodium—Flatulence—Doxorubicin—muscle cancer	0.00138	0.00138	CcSEcCtD
Fondaparinux sodium—Chest pain—Methotrexate—muscle cancer	0.00138	0.00138	CcSEcCtD
Fondaparinux sodium—Dysgeusia—Doxorubicin—muscle cancer	0.00137	0.00137	CcSEcCtD
Fondaparinux sodium—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—muscle cancer	0.00137	0.00137	CcSEcCtD
Fondaparinux sodium—Back pain—Doxorubicin—muscle cancer	0.00135	0.00135	CcSEcCtD
Fondaparinux sodium—Confusional state—Methotrexate—muscle cancer	0.00133	0.00133	CcSEcCtD
Fondaparinux sodium—Anaphylactic shock—Methotrexate—muscle cancer	0.00132	0.00132	CcSEcCtD
Fondaparinux sodium—Vision blurred—Doxorubicin—muscle cancer	0.00132	0.00132	CcSEcCtD
Fondaparinux sodium—Infection—Methotrexate—muscle cancer	0.00131	0.00131	CcSEcCtD
Fondaparinux sodium—Nausea—Etoposide—muscle cancer	0.00131	0.00131	CcSEcCtD
Fondaparinux sodium—Nervous system disorder—Methotrexate—muscle cancer	0.00129	0.00129	CcSEcCtD
Fondaparinux sodium—Anaemia—Doxorubicin—muscle cancer	0.00129	0.00129	CcSEcCtD
Fondaparinux sodium—Thrombocytopenia—Methotrexate—muscle cancer	0.00129	0.00129	CcSEcCtD
Fondaparinux sodium—Skin disorder—Methotrexate—muscle cancer	0.00128	0.00128	CcSEcCtD
Fondaparinux sodium—Hyperhidrosis—Methotrexate—muscle cancer	0.00128	0.00128	CcSEcCtD
Fondaparinux sodium—Vertigo—Doxorubicin—muscle cancer	0.00126	0.00126	CcSEcCtD
Fondaparinux sodium—Anorexia—Methotrexate—muscle cancer	0.00126	0.00126	CcSEcCtD
Fondaparinux sodium—Syncope—Doxorubicin—muscle cancer	0.00126	0.00126	CcSEcCtD
Fondaparinux sodium—Palpitations—Doxorubicin—muscle cancer	0.00124	0.00124	CcSEcCtD
Fondaparinux sodium—Hypotension—Methotrexate—muscle cancer	0.00123	0.00123	CcSEcCtD
Fondaparinux sodium—Loss of consciousness—Doxorubicin—muscle cancer	0.00123	0.00123	CcSEcCtD
Fondaparinux sodium—Cough—Doxorubicin—muscle cancer	0.00122	0.00122	CcSEcCtD
Fondaparinux sodium—Convulsion—Doxorubicin—muscle cancer	0.00121	0.00121	CcSEcCtD
Fondaparinux sodium—Insomnia—Methotrexate—muscle cancer	0.00119	0.00119	CcSEcCtD
Fondaparinux sodium—Chest pain—Doxorubicin—muscle cancer	0.00119	0.00119	CcSEcCtD
Fondaparinux sodium—Anxiety—Doxorubicin—muscle cancer	0.00119	0.00119	CcSEcCtD
Fondaparinux sodium—Paraesthesia—Methotrexate—muscle cancer	0.00119	0.00119	CcSEcCtD
Fondaparinux sodium—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—muscle cancer	0.00118	0.00118	CcSEcCtD
Fondaparinux sodium—Dyspnoea—Methotrexate—muscle cancer	0.00118	0.00118	CcSEcCtD
Fondaparinux sodium—Somnolence—Methotrexate—muscle cancer	0.00117	0.00117	CcSEcCtD
Fondaparinux sodium—Dyspepsia—Methotrexate—muscle cancer	0.00116	0.00116	CcSEcCtD
Fondaparinux sodium—Confusional state—Doxorubicin—muscle cancer	0.00115	0.00115	CcSEcCtD
Fondaparinux sodium—Decreased appetite—Methotrexate—muscle cancer	0.00115	0.00115	CcSEcCtD
Fondaparinux sodium—Oedema—Doxorubicin—muscle cancer	0.00114	0.00114	CcSEcCtD
Fondaparinux sodium—Anaphylactic shock—Doxorubicin—muscle cancer	0.00114	0.00114	CcSEcCtD
Fondaparinux sodium—Gastrointestinal disorder—Methotrexate—muscle cancer	0.00114	0.00114	CcSEcCtD
Fondaparinux sodium—Fatigue—Methotrexate—muscle cancer	0.00114	0.00114	CcSEcCtD
Fondaparinux sodium—Infection—Doxorubicin—muscle cancer	0.00114	0.00114	CcSEcCtD
Fondaparinux sodium—Pain—Methotrexate—muscle cancer	0.00113	0.00113	CcSEcCtD
Fondaparinux sodium—Shock—Doxorubicin—muscle cancer	0.00112	0.00112	CcSEcCtD
Fondaparinux sodium—Nervous system disorder—Doxorubicin—muscle cancer	0.00112	0.00112	CcSEcCtD
Fondaparinux sodium—Thrombocytopenia—Doxorubicin—muscle cancer	0.00112	0.00112	CcSEcCtD
Fondaparinux sodium—Tachycardia—Doxorubicin—muscle cancer	0.00112	0.00112	CcSEcCtD
Fondaparinux sodium—Skin disorder—Doxorubicin—muscle cancer	0.00111	0.00111	CcSEcCtD
Fondaparinux sodium—Hyperhidrosis—Doxorubicin—muscle cancer	0.00111	0.00111	CcSEcCtD
Fondaparinux sodium—Anorexia—Doxorubicin—muscle cancer	0.00109	0.00109	CcSEcCtD
Fondaparinux sodium—Feeling abnormal—Methotrexate—muscle cancer	0.00109	0.00109	CcSEcCtD
Fondaparinux sodium—Gastrointestinal pain—Methotrexate—muscle cancer	0.00108	0.00108	CcSEcCtD
Fondaparinux sodium—Hypotension—Doxorubicin—muscle cancer	0.00107	0.00107	CcSEcCtD
Fondaparinux sodium—Urticaria—Methotrexate—muscle cancer	0.00105	0.00105	CcSEcCtD
Fondaparinux sodium—Abdominal pain—Methotrexate—muscle cancer	0.00104	0.00104	CcSEcCtD
Fondaparinux sodium—Body temperature increased—Methotrexate—muscle cancer	0.00104	0.00104	CcSEcCtD
Fondaparinux sodium—Insomnia—Doxorubicin—muscle cancer	0.00103	0.00103	CcSEcCtD
Fondaparinux sodium—Paraesthesia—Doxorubicin—muscle cancer	0.00103	0.00103	CcSEcCtD
Fondaparinux sodium—Dyspnoea—Doxorubicin—muscle cancer	0.00102	0.00102	CcSEcCtD
Fondaparinux sodium—Somnolence—Doxorubicin—muscle cancer	0.00102	0.00102	CcSEcCtD
Fondaparinux sodium—Dyspepsia—Doxorubicin—muscle cancer	0.00101	0.00101	CcSEcCtD
Fondaparinux sodium—Decreased appetite—Doxorubicin—muscle cancer	0.000994	0.000994	CcSEcCtD
Fondaparinux sodium—Gastrointestinal disorder—Doxorubicin—muscle cancer	0.000987	0.000987	CcSEcCtD
Fondaparinux sodium—Fatigue—Doxorubicin—muscle cancer	0.000986	0.000986	CcSEcCtD
Fondaparinux sodium—Constipation—Doxorubicin—muscle cancer	0.000978	0.000978	CcSEcCtD
Fondaparinux sodium—Pain—Doxorubicin—muscle cancer	0.000978	0.000978	CcSEcCtD
Fondaparinux sodium—Hypersensitivity—Methotrexate—muscle cancer	0.000973	0.000973	CcSEcCtD
Fondaparinux sodium—Asthenia—Methotrexate—muscle cancer	0.000947	0.000947	CcSEcCtD
Fondaparinux sodium—Feeling abnormal—Doxorubicin—muscle cancer	0.000942	0.000942	CcSEcCtD
Fondaparinux sodium—Gastrointestinal pain—Doxorubicin—muscle cancer	0.000935	0.000935	CcSEcCtD
Fondaparinux sodium—Pruritus—Methotrexate—muscle cancer	0.000934	0.000934	CcSEcCtD
Fondaparinux sodium—Urticaria—Doxorubicin—muscle cancer	0.000908	0.000908	CcSEcCtD
Fondaparinux sodium—Abdominal pain—Doxorubicin—muscle cancer	0.000904	0.000904	CcSEcCtD
Fondaparinux sodium—Body temperature increased—Doxorubicin—muscle cancer	0.000904	0.000904	CcSEcCtD
Fondaparinux sodium—Diarrhoea—Methotrexate—muscle cancer	0.000903	0.000903	CcSEcCtD
Fondaparinux sodium—Dizziness—Methotrexate—muscle cancer	0.000873	0.000873	CcSEcCtD
Fondaparinux sodium—Hypersensitivity—Doxorubicin—muscle cancer	0.000842	0.000842	CcSEcCtD
Fondaparinux sodium—Vomiting—Methotrexate—muscle cancer	0.000839	0.000839	CcSEcCtD
Fondaparinux sodium—Rash—Methotrexate—muscle cancer	0.000832	0.000832	CcSEcCtD
Fondaparinux sodium—Dermatitis—Methotrexate—muscle cancer	0.000832	0.000832	CcSEcCtD
Fondaparinux sodium—Headache—Methotrexate—muscle cancer	0.000827	0.000827	CcSEcCtD
Fondaparinux sodium—Asthenia—Doxorubicin—muscle cancer	0.00082	0.00082	CcSEcCtD
Fondaparinux sodium—Pruritus—Doxorubicin—muscle cancer	0.000809	0.000809	CcSEcCtD
Fondaparinux sodium—Nausea—Methotrexate—muscle cancer	0.000784	0.000784	CcSEcCtD
Fondaparinux sodium—Diarrhoea—Doxorubicin—muscle cancer	0.000782	0.000782	CcSEcCtD
Fondaparinux sodium—Dizziness—Doxorubicin—muscle cancer	0.000756	0.000756	CcSEcCtD
Fondaparinux sodium—Vomiting—Doxorubicin—muscle cancer	0.000727	0.000727	CcSEcCtD
Fondaparinux sodium—Rash—Doxorubicin—muscle cancer	0.000721	0.000721	CcSEcCtD
Fondaparinux sodium—Dermatitis—Doxorubicin—muscle cancer	0.00072	0.00072	CcSEcCtD
Fondaparinux sodium—Headache—Doxorubicin—muscle cancer	0.000716	0.000716	CcSEcCtD
Fondaparinux sodium—Nausea—Doxorubicin—muscle cancer	0.000679	0.000679	CcSEcCtD
